← Leaderboards
Charles P Rodi
Rodi Pharma, Inc.
$400,000
Attributed
$400,000
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $300K · FY2005–10$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$400,000 · 2
By mechanism
R41$300,000 · 1
R43$100,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Adjuvant”
- Lawrence Corey · Fred Hutchinson Cancer Center$377,142,999
- Norman Wolmark · Nsabp Foundation, Inc.$267,141,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$167,183,168
- David Heimbrook · Leidos Biomedical Research, Inc.$151,668,128
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$131,206,481
- Peter B. Gilbert · Fred Hutchinson Cancer Center$117,668,001
Research focus
AdjuvantAids/Hiv ProblemAmericanAnimalsAntibioticsAntibiotic TherapyAntibodiesBacteremiaBacteriaBacterial Antibiotic ResistanceBacterial InfectionsBaiap1 GeneBaseCarrier ProteinsCenters For Disease Control And Prevention (U.S.)ChemistryClinically RelevantCombatDesignDrug Discovery /IsolationDrug ResistanceDrug Screening /EvaluationEnzymesActive Immunization